These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1829992)
1. Thromboxane A2 receptor stimulation similarly potentiates pressor responses to 5-hydroxytryptamine in perfused hindquarters of non-diabetic and alloxan diabetic rats. Sikorski BW; Hodgson WC; King RG Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):237-44. PubMed ID: 1829992 [TBL] [Abstract][Full Text] [Related]
2. Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat. Hodgson WC; King RG; Boura AL J Pharm Pharmacol; 1990 Jun; 42(6):423-7. PubMed ID: 1979623 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity changes of the perfused hindquarters' vasculature in rats with alloxan-induced diabetes mellitus. Boura AL; Hodgson WC; King RG Clin Exp Pharmacol Physiol; 1987 May; 14(5):481-7. PubMed ID: 3677485 [TBL] [Abstract][Full Text] [Related]
4. Changes in reactivity towards 5-hydroxytryptamine in the renal vasculature of the diabetic spontaneously hypertensive rat. Boston PC; Hodgson WC J Hypertens; 1997 Jul; 15(7):769-74. PubMed ID: 9222945 [TBL] [Abstract][Full Text] [Related]
5. Attenuated 5-HT2 receptor-mediated responses in hindquarters of diabetic rats. James GM; Hodgson WC Eur J Pharmacol; 1995 Dec; 294(1):109-15. PubMed ID: 8788422 [TBL] [Abstract][Full Text] [Related]
6. Influence of SQ 29,548 on vasoconstrictor responses in the hindquarters vascular bed of the cat. Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ Prostaglandins Leukot Essent Fatty Acids; 1991 Oct; 44(2):83-8. PubMed ID: 1836063 [TBL] [Abstract][Full Text] [Related]
7. Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid. Boura AL; Hodgson WC; King RG Br J Pharmacol; 1986 Nov; 89(3):613-8. PubMed ID: 3099877 [TBL] [Abstract][Full Text] [Related]
8. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848. Arner M; Högestätt ED; Uski TK Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448 [TBL] [Abstract][Full Text] [Related]
9. Potentiation by endothelin-1 of 5-hydroxytryptamine responses in aortae from streptozotocin-diabetic rats: a role for thromboxane A2. James GM; Hodgson WC Br J Pharmacol; 1995 Mar; 114(6):1236-40. PubMed ID: 7620714 [TBL] [Abstract][Full Text] [Related]
10. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Cocks TM; Kemp BK; Pruneau D; Angus JA Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898 [TBL] [Abstract][Full Text] [Related]
11. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery. He GW; Yang CQ J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353 [TBL] [Abstract][Full Text] [Related]
12. Influence of the thromboxane-mimetic U-46619 and the prostacyclin metabolite 6-keto prostaglandin E1 on vasoconstriction induced by noradrenaline and 5-HT in rat mesenteric vasculature. Stanton BJ; Coupar IM Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):7-12. PubMed ID: 3186779 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of glibenclamide on responses to thromboxane A2 mimic, U46619, in the pulmonary and hindquarters vascular beds of the cat. Kaye AD; Nossaman BD; Santiago JA; DeWitt BJ; Ibrahim IN; Kadowitz PJ Eur J Pharmacol; 1997 Dec; 340(2-3):187-93. PubMed ID: 9537814 [TBL] [Abstract][Full Text] [Related]
14. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney. Rump LC; Schollmeyer P Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228 [TBL] [Abstract][Full Text] [Related]
15. The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo. Fukuhara M; Neves LA; Li P; Diz DI; Ferrario CM; Brosnihan KB J Hypertens; 2001 Mar; 19(3 Pt 2):561-6. PubMed ID: 11327630 [TBL] [Abstract][Full Text] [Related]
16. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery. Templeton AG; McGrath JC; Whittle MJ Br J Pharmacol; 1991 May; 103(1):1079-84. PubMed ID: 1878747 [TBL] [Abstract][Full Text] [Related]
17. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Quilley J; McGiff JC; Nasjletti A Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332 [TBL] [Abstract][Full Text] [Related]
18. The influence of hyperthyroidism on pharmacologically induced contractions of isolated resistance arteries. Zwaveling J; Prins EA; Maas MA; Pfaffendorf M; Van Zwieten PA Eur J Pharmacol; 1996 Apr; 300(1-2):91-7. PubMed ID: 8741171 [TBL] [Abstract][Full Text] [Related]
19. U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies. Read MA; Leitch IM; Giles WB; Bisits AM; Boura AL; Walters WA J Hypertens; 1999 Mar; 17(3):389-96. PubMed ID: 10100077 [TBL] [Abstract][Full Text] [Related]
20. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Choppin A; O'Connor SE Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]